Table 1 Baseline characteristics.

From: Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial

 

HBOT arm

Long term HBOT

P

N

37

31

 

Age (Y)

48.4 ± 10.6

46.7 ± 11.5

0.532

Males

18 (48.6)

14 (45.2)

0.774

Female

19 (51.4)

17 (54.8)

0.774

BMI (kg/m2)

26.9 ± 5.1

26.8 ± 5.0

0.944

Years of education

14.6 ± 2.7

14.8 ± 2.5

0.845

Marital status

  

0.955

 Single

5 (13.5)

5 (16.1)

 

 Married

27 (73.0)

23 (74.2)

 

 Divorced

3 (8.1)

2 (6.5)

 

 Widowed

2 (5.4)

1 (3.2)

 

Number of children

2.5 ± 1.4

2.2 ± 1.5

0.422

Employment status

33 (89.2)

27 (87.1)

1.000 (F)

Time from infection (days)

159.1 ± 71.3

158.3 ± 76.1

0.989

MoCA—cognitive assessment

25.4 ± 3.6

25.5 ± 3.6

0.843

Hospitalized*

4 (10.8)

3 (9.7)

1.000 (F)

High risk conditions

 BMI > 30

11 (29.7)

9 (29.0)

1.000 (F)

 Age > 60 Y

4 (10.8)

2 (6.5)

0.681 (F)

 Cancer

0 (0.0)

0 (0.0)

1.000 (F)

 Diabetes mellitus

1 (2.7)

1 (3.2)

1.000 (F)

 Hypertension

4 (10.8)

3 (9.7)

1.000 (F)

 Heart disease

1 (2.7)

0 (0.0)

1.000 (F)

 Immune deficiency

0 (0.0)

0 (0.0)

1.000 (F)

 Asthma

2 (5.4)

1 (3.2)

1.000 (F)

 Other chronic lung diseases

0 (0.0)

0 (0.0)

1.000 (F)

 Chronic liver disease

0 (0.0)

0 (0.0)

1.000 (F)

 Chronic kidney disease

0 (0.0)

0 (0.0)

1.000 (F)

 Hematologic disease\disorder

0 (0.0)

0 (0.0)

1.000 (F)

 Chronic neurological impairment\disease

1 (2.7)

1 (2.7)

1.000 (F)

 Smoking

  Current

0 (0.0)

0 (0.0)

1.000 (F)

  Previous

10 (27.0)

8 (25.8)

0.910

  1. Data presented as n (%); continuous data, mean ± SD; The body-mass index is the weight in kilograms divided by the square of the height in meters. (F): Fisher’s exact test.
  2. *During COVID19 infection; MoCA, Montreal Cognitive Assessment.